Whole Exome Sequencing of Familial and Pediatric Forms of Vasculitis
Recruiting
- Conditions
- Vasculitis
- Registration Number
- NCT04006535
- Lead Sponsor
- Benjamin Terrier
- Brief Summary
The FAMILYVASC study is a prospective observational study which will aim to identify susceptibility loci and genes for systemic vasculitis risk in patients with familial or pediatric forms of vasculitis. Genetic analysis based on whole exome sequencing will be carried out through salivary DNA.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Not provided
Exclusion Criteria
Not provided
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Identification of susceptibility loci and genes At the moment of enrollment
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie systemic vasculitis susceptibility identified in NCT04006535 whole exome sequencing study?
How does familial vasculitis genetic profiling from NCT04006535 compare to pediatric vasculitis biomarker discovery efforts?
What immune-related biomarkers from salivary DNA analysis in NCT04006535 predict vasculitis treatment response?
Are there novel therapeutic targets emerging from exome sequencing data in the FAMILYVASC vasculitis study?
How might NCT04006535 findings on vasculitis susceptibility genes influence development of biologic therapies for granulomatous vasculitis?
Trial Locations
- Locations (1)
Hôpital Cochin - Department of Internal Medicine
🇫🇷Paris, Ile De France, France
Hôpital Cochin - Department of Internal Medicine🇫🇷Paris, Ile De France, FranceBenjamin Terrier, MD, PhDContact+ 01 58 41 14 61benjamin.terrier@aphp.fr